A detailed history of Braidwell LP transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Braidwell LP holds 1,357,490 shares of ADPT stock, worth $4.6 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
1,357,490
Previous 1,357,490 -0.0%
Holding current value
$4.6 Million
Previous $6.65 Billion 34.49%
% of portfolio
0.14%
Previous 0.24%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$3.46 - $5.33 $1.35 Million - $2.08 Million
389,800 Added 40.28%
1,357,490 $6.65 Billion
Q3 2023

Nov 14, 2023

BUY
$5.07 - $8.44 $1.62 Million - $2.69 Million
319,239 Added 49.23%
967,690 $5.27 Billion
Q1 2023

May 15, 2023

BUY
$7.8 - $10.11 $5.06 Million - $6.56 Million
648,451 New
648,451 $5.73 Billion

Others Institutions Holding ADPT

About Adaptive Biotechnologies Corp


  • Ticker ADPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 142,872,992
  • Market Cap $484M
  • Description
  • Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...
More about ADPT
Track This Portfolio

Track Braidwell LP Portfolio

Follow Braidwell LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Braidwell LP, based on Form 13F filings with the SEC.

News

Stay updated on Braidwell LP with notifications on news.